Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Condition:   Benign Prostatic Hyperplasia Interventions:   Drug: DKF-313;   Drug: Dutasteride;   Drug: Tadalafil;   Drug: DKF-313 placebo;   Drug: Dutasteride placebo;   Drug: Tadalafil placebo Sponsor:   Dongkook Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials